Human papillomavirus type 16-immortalized endocervical cells selected for resistance to cisplatin are malignantly transformed and have a multidrug resistance phenotype

International Journal of Cancer

Volumn 87, Issue 6, 2000, Pages 818-823

  Ding, Zhihu ^a   Yang, Xiaolong ^a   Chernenko, Garry ^a   Tang, Shou Ching ^a,b   Pater, Alan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Newfoundland Cancer Foundation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL IMMORTALIZATION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; CISPLATIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HELA CELLS; HUMANS; MICE; MICE, NUDE; PAPILLOMAVIRIDAE; PHENOTYPE; TUMOR STEM CELL ASSAY;

EID: 0033836234     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000915)87:6<818::AID-IJC10>3.0.CO;2-M     Document Type: Article

References (35)

1. Human papillomaviruses and associated malignancies
2. Aetiology, pathogenesis, and pathology of cervical neoplasia
3. The induction of multidrug resistance in human cervical carcinoma cell lines by estrogenic hormones
4. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance
5. Resistance to apoptosis correlated with the enhanced expression of anti-apoptotic proteins in human cervical cisplatin-resistant cells
6. Role of oncogenes in resistance and killing by cancer therapeutic agents
7. Is cisplatin a human carcinogen?
8. Apoptosis and the dilemma of cancer chemotherapy
9. The carcinogenicity of anticancer drugs: A hazard in man
10. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
11. Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors
12. Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype
13. Challenging drug resistance in cancer therapy - Review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997
14. Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens
15. Endogenous tumor necrosis factor functions as a resistant factor against Adriamycin
16. Apoptosis in tumorigenesis and cancer therapy
17. 6-methylguaninedeoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas
18. Malignant transformation of human ectocervical cells immortalized by HPV 18: In vitro model of carcinogenesis by cigarette smoke
19. Molecular mechanisms of multidrug resistance in cancer chemotherapy
20. Estimates of the worldwide incidence of 25 major cancers in 1990
21. Glucocorticoid-dependent oncogenic transformation by type 16 but not type II human papilloma virus DNA
22. Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells
23. Estimates of the worldwide mortality from 25 cancers in 1990
24. Precancer of the human cervix
25. Monitoring of occupational exposure to cytostatic anticancer agents
26. Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells
27. Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix
28. Growth and characterization of epithelial cells from normal human uterine ectocervix and endocervix. In Vitro
29. Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance
30. Benign proliferative reactions, intraepithelial neoplasias and invasive cancer of the uterine cervix
31. BAG- 1 promotes apoptosis induced by N-(4- hydroxyphenyl)retinamide in human cervical carcinoma cells
32. Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis
33. Human papillomavirus 18-immortalized endocervical cells with in vitro cytokeratin expression characteristics of adenocarcinoma
34. Papillomaviruses in human cancers
35. Human papillomaviruses